SCHEMBL4072047

SCHEMBL4072047

C[C@@H](O)C(=O)N1CC[CH]CC1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
DPP4 P27487 2/20 0.35
DPP7 Q9UHL4 2/20 0.35
DPP8 Q6V1X1 1/20 0.35
RORC P51449 2/20 0.33
ROCK2 O75116 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
TP53 P04637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HTT P42858 1/20 0.32
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP8 P22894 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1098525 1.00 ALDH1A1 (0.35) ALDH1A1MEN1KMT2ADPP4DPP7
SCHEMBL2248603 0.87 DPP7 (0.40) DPP4DPP7DPP8
SCHEMBL1587326 0.84 CHRNB2 (0.42) ALDH1A1MEN1KMT2ADPP4DPP7
SCHEMBL13324885 0.83 MEN1 (0.41) ALDH1A1MEN1KMT2ARORCROCK2
SCHEMBL3319718 0.80 DPP4 (0.41) DPP4DPP7DPP8CYP3A4
SCHEMBL3311754 0.80 DPP4 (0.41) DPP4DPP7DPP8CYP3A4
SCHEMBL3353105 0.78 ALDH1A1 (0.33) ALDH1A1MEN1KMT2ADPP4DPP7
SCHEMBL3298525 0.78 MMP1 (0.44) ALDH1A1MEN1KMT2ADPP4DPP7
SCHEMBL1417346 0.78 MMP1 (0.44) ALDH1A1MEN1KMT2ADPP4DPP7
SCHEMBL3288873 0.78 MMP1 (0.44) ALDH1A1MEN1KMT2ADPP4DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270450-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2009-10-29 US claimed
EP-2084134-A1 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2009-08-05 EP claimed
WO-2008056148-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-05-15 WO claimed
US-20090270450-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2009-10-29 US disclosed
EP-2084134-A1 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2009-08-05 EP disclosed
WO-2008056148-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270450-A1 CHEMICAL COMPOUNDS CSF1R, CSF3R, FLT3 ALDH1A1 753/4885MEN1 291/4885KMT2A 1288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.